Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

NCT07332858 is registered in ClinicalTrials.gov with Gang Hou as lead sponsor.

NCT NCT07332858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07332858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
Lead sponsor
Gang Hou
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 24, 2026
Completion date
October 30, 2028
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural effusions (mpe), non small cell lung cancer